Targeted Mild Hypercapnia and Right Ventricular Function After OHCA
The TAME trial was an 2023 RCT that assessed neurologic outcomes with targeted mild hypercapnia vs normocapnia in patients with out-of-hospital cardiac arrest (OHCA) who achieved return of spontaneous circulation ...


